Ballicules.com

Clindamycin

CLEOCIN

What it isLincosamide that inhibits the bacterial 50S ribosome; anaerobic, dental, and skin infections.

Why this oneAnaerobic and gram-positive coverage plus toxin suppression makes it especially useful in necrotizing infection.

What limits itIt is the classic antibiotic trigger for C. difficile colitis; inducible staphylococcal resistance may require a D-test.

FDA-approved for

FDA label

BOXED WARNING Clostridioides difficile-associated diarrhea (may range to fatal colitis); reserve for serious infections where less toxic antimicrobials are inappropriate.
FDA dosingPopulationStartTargetMax
Serious infectionsAdult150-300 mg q6h (QID)
More severe infectionsAdult300-450 mg q6h (QID)
Serious infectionsPediatric8-16 mg/kg/day divided in 3-4 doses
More severe infectionsPediatric16-20 mg/kg/day divided in 3-4 doses

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Systemic use in 2nd and 3rd trimesters not associated with increased congenital abnormalities; use in the first trimester only if clearly needed.

Lactation Undefined

NO BOXED WARNINGS

Principal riskClostridioides difficile colitis

Cost, est. cash$10–$500/month

Generic entryPre-1982

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryB

Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Mechanism of action: Clindamycin ballicule

Clindamycin ballicule: receptor binding, kinetics and half-life diagram

Open Clindamycin in the interactive console ↗

Memory aids: mascots and interaction avatars

Clindamycin CLEOCIN mascot mnemonic cartoon
“Clean the mice Cleopatra”

Open Clindamycin in the interactive console ↗